The role of platelets in the development and progression of pulmonary arterial hypertension

Adv Med Sci. 2018 Sep;63(2):312-316. doi: 10.1016/j.advms.2018.04.013. Epub 2018 Jun 7.

Abstract

Pulmonary arterial hypertension is a multifactorial disease characterized by vasoconstriction, vascular remodeling, inflammation and thrombosis. Although an increasing number of research confirmed that pulmonary artery endothelial cells, pulmonary artery smooth muscle cells as well as platelets have a role in the pulmonary arterial hypertension pathogenesis, it is still unclear what integrates these factors. In this paper, we review the evidence that platelets through releasing a large variety of chemokines could actively impact the pulmonary arterial hypertension pathogenesis and development. A recent publication revealed that not only an excess of platelet derived cytokines, but also a deficiency may be associated with pulmonary arterial hypertension development and progression. Hence, a simple platelet blockade may not be a correct action to treat pulmonary arterial hypertension. Our review aims to analyse the interactions between the platelets and different types of cells involved in pulmonary arterial hypertension pathogenesis. This knowledge could help to find novel therapeutic options and improve prognosis in this devastating disease.

Keywords: Platelets; Pulmonary arterial hypertension.

Publication types

  • Review

MeSH terms

  • Animals
  • Blood Platelets / pathology*
  • Chemokines / metabolism
  • Disease Progression*
  • Humans
  • Hypertension, Pulmonary / blood*
  • Hypertension, Pulmonary / pathology*
  • Pulmonary Artery / pathology*
  • Serotonin / metabolism

Substances

  • Chemokines
  • Serotonin